Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Maha S Al-Keilani"'
Autor:
Maha S Al-Keilani, Samah Awad, Hanan M Hammouri, Tala Al Shalakhti, Basima A Almomani, Muna M Dahabreh, Mohammad-Jaafar Ajlony
Publikováno v:
PLoS ONE, Vol 18, Iss 5, p e0284511 (2023)
BackgroundObjective monitoring of improvement during treatment of pulmonary exacerbation can be difficulty in children when pulmonary function testing cannot be obtained. Thus, the identification of predictive biomarkers to determine the efficacy of
Externí odkaz:
https://doaj.org/article/81c7e3f457724d98bd37d2e6baa5d3f3
Publikováno v:
PLoS ONE, Vol 16, Iss 6, p e0252616 (2021)
BackgroundThe neuropeptide substance P is a potential biomarker and therapeutic target in cancer. The main objectives of this study were to investigate the expression level of substance P in different breast cancer molecular subtypes and identify its
Externí odkaz:
https://doaj.org/article/c5f58eec8b854c3aab7edc7e87a4ed04
Publikováno v:
PLoS ONE, Vol 15, Iss 6, p e0235001 (2020)
Effective adoption of genetics in clinical practice requires the support of and interaction between the different partners of healthcare system; healthcare professionals (HCPs) and patients. The study aimed to assess and compare the knowledge, factor
Externí odkaz:
https://doaj.org/article/9d2771d5c8b4459c8c6e05340cbd9aa4
Autor:
Mohammad A Y Alqudah, Supreet Agarwal, Maha S Al-Keilani, Zita A Sibenaller, Timothy C Ryken, Mahfoud Assem
Publikováno v:
PLoS ONE, Vol 8, Iss 10, p e77299 (2013)
Using a GWA analysis of a comprehensive glioma specimen population, we identified whole gain of chromosome 19 as one of the major chromosomal aberrations that correlates to patients' outcomes. Our analysis of significant loci revealed for the first t
Externí odkaz:
https://doaj.org/article/c371aaeda9314b04a597298d572c85af
Autor:
Supreet Agarwal, Maha S Al-Keilani, Mohammad A Y Alqudah, Zita A Sibenaller, Timothy C Ryken, Mahfoud Assem
Publikováno v:
PLoS ONE, Vol 8, Iss 5, p e62852 (2013)
Poor prognosis and resistance to therapy in malignant gliomas is mainly due to the highly dispersive nature of glioma cells. This dispersive characteristic results from genetic alterations in key regulators of cell migration and diffusion. A better u
Externí odkaz:
https://doaj.org/article/51b3767bbf704c0cb409be4ce0f499dd
Publikováno v:
International Journal of Breast Cancer, Vol 2022 (2022)
Background. Neurokinin 1 receptor (NK1R) is a promising biomarker and therapeutic target in breast cancer. This study was aimed at investigating the expression level of NK1R in breast cancer tissues and its relationship with proliferation index as me
Externí odkaz:
https://doaj.org/article/20ef8ac0a1b146feb4228e76d59e5f1f
Autor:
Maha S Al-Keilani, Basima A Almomani
Publikováno v:
International Journal of Pharmacy Practice. 31:198-205
Objectives To evaluate medication adherence to oral and parenteral disease-modifying therapies (DMTs) and to explore factors associated with medication non-adherence in patients with multiple sclerosis (MS). Methods A cross-sectional multicentre stud
Autor:
Mohammad A. Al-Qudah, Maha S. Al-Keilani, Marya Obeidat, Husam K. Haddad, Roba Bdeir, Lina M. Samman
Publikováno v:
Applied Immunohistochemistry & Molecular Morphology.
Autor:
Maha S. Al-Keilani, Mohammad A. Alqudah, Basima A. Almomani, Moath M. Alrjoub, Batool A. Shhabat, Karem H. Alzoubi
Publikováno v:
Current Cancer Drug Targets. 23
Background: Neovascularization is essential for the growth and progression of tumor tissues. GRP78 is frequently overexpressed in various cancers and has been suggested as a proangiogenic factor. Purpose: This study aimed to investigate the expressio
Autor:
Maha S. Al-Keilani, Basima A. Almomani, Saied A. Jaradat, Nour A. Al-Sawalha, Majdi Al Qawasmeh
Publikováno v:
CNS & Neurological Disorders - Drug Targets. 22
Background: Alpha calcitonin gene-related peptide (aCGRP), neuropeptide Y (NPY), and substance P (SP) are neuropeptides that have emerged recently as potent immunomodulatory factors with potential as novel biomarkers and therapeutic targets in multip